Imipenem/Cilastatin Sodium in the Treatment of Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis
作者:
Siu-Fai Lui,
Augustine B. Cheng,
Chi-Bon Leung,
Kong-Chiu Wong,
Philip K.T. Li,
Kar-Neng Lai,
期刊:
American Journal of Nephrology
(Karger Available online 1994)
卷期:
Volume 14,
issue 3
页码: 182-186
ISSN:0250-8095
年代: 1994
DOI:10.1159/000168711
出版商: S. Karger AG
关键词: Continuous peritoneal dialysis;Peritonitis;Imipenem
数据来源: Karger
摘要:
Imipenem/cilastatin sodium is a new thienamycin class of antibiotic with a broad spectrum of bactericidal activities. It may be a suitable single first-line therapy for the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients. Fifty episodes of CAPD peritonitis were treated with imipenem/cilastatin sodium. On presentation, all patients were given an intravenous loading dose of 1 g of imipenem/cilastatin sodium followed by intraperitoneal imipenem/cilastatin sodium for 10 days. During 1989 (30 episodes), 20 mg imipenem/cilastatin sodium was added to each 2-liter bag of peritoneal dialysis (PD) fluid for 10 days. The primary response rate as defined by polymorphonuclear neutrophils < 100/ml in PD fluid was 90%. Unfortunately, 17% of the peritonitis relapsed within 14 days of stopping antibiotic. The complete cure rate without relapse was therefore 73%. During 1990 (20 episodes), 100 mg imipenem/cilastatin sodium was added to each 2-liter bag of PD fluid for 10 days. The primary response rate was 95%, the complete cure rate without relapse was 85%. Imipenem/cilastatin sodium is an effective single first-line antibiotic for the treatment of peritonitis in CAPD.
点击下载:
PDF
(896KB)
返 回